From: What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
Antiproliferative agents: |
Angiopeptin |
Low-molecular weight heparin |
Antimetabolites: |
Methotrexate |
Antithrombotic agents: |
Hirulog |
Antithrombin III |
Monoclonal antibodies: |
Growth factors |
Adhesion molecules |
Cytokines |
Antihypertensive agents: |
Calcium channel blockers |
ACE inhibitors |
New immunosuppressive agents |
Use of photopheresis |
Lipid-lowering agents: |
HMG-CoA reductase inhibitors |